---
id: aha-vhd-2025
title: "2025 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease"
short_title: "Valvular Heart Disease"
organization: American Heart Association / American College of Cardiology
country: United States
url: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001216
specialty: cardiology
guideline_type: clinical-practice
evidence_system: acc-aha
conditions:
  - Aortic Valve Stenosis
  - Aortic Valve Regurgitation
  - Mitral Valve Stenosis
  - Mitral Valve Regurgitation
  - Tricuspid Valve Disease
  - Prosthetic Heart Valves
tags:
  - valvular heart disease
  - structural heart disease
  - TAVR
  - mitral repair
  - infective endocarditis
publication_date: 2025-01-15
previous_version_date: 2020-12-17
status: current
supersedes: aha-vhd-2020
superseded_by: null
pdf_path: null
has_pdf: false
last_reviewed: 2025-01-01
---

## Scope

This guideline provides comprehensive recommendations for the evaluation and management of adults with valvular heart disease (VHD), including native valve disease, prosthetic valve management, and infective endocarditis.

## Key Recommendations

### Aortic Stenosis (AS)
- Symptomatic severe AS: Aortic valve intervention recommended (Class I)
- Asymptomatic severe AS with LVEF <50%: Intervention recommended
- TAVR vs SAVR: Age and surgical risk stratification updated
- Low-flow, low-gradient AS: Dobutamine stress echo for evaluation

### Aortic Regurgitation (AR)
- Symptomatic severe AR: Surgery recommended (Class I)
- Asymptomatic severe AR with LVEF â‰¤55% or LVESD >50mm: Surgery recommended
- Serial imaging for monitoring disease progression

### Mitral Regurgitation (MR)
- Primary MR: Mitral repair preferred over replacement when feasible
- Secondary MR: Medical therapy optimization first-line
- Transcatheter edge-to-edge repair: Expanded indications for secondary MR

### Mitral Stenosis (MS)
- Symptomatic severe MS with favorable anatomy: PMBV recommended
- Unfavorable anatomy or concomitant MR: Surgical intervention

### Tricuspid Valve Disease
- Severe TR at time of left-sided valve surgery: Concomitant tricuspid repair
- Isolated severe symptomatic TR: Surgical or transcatheter intervention considered

### Prosthetic Valve Management
- Anticoagulation for mechanical valves: INR targets specified
- Bioprosthetic valve surveillance: Echocardiographic monitoring schedule
- Valve thrombosis: Anticoagulation vs intervention decision pathway

### Infective Endocarditis
- Antibiotic prophylaxis: High-risk patients and procedures
- Early surgery indications: Heart failure, uncontrolled infection, embolic prevention
